drugset / Trial / NCT00375934

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

NCT00375934

Phase 3 Completed 200 enrolled Xanodyne Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.

Timeline

Start
2006-09
Primary completion
2007-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 25 mg

Indications